stars 1 stars 2 stars 3

Syntensor is building software that converts large biological datasets into decisions. To predict clinical trial outcomes, the Syntensor platform first simulates a comprehensive suite of potency and ADMET assays; collectively, these two areas account for 60-70% of clinical trial failures. The model considers these predictions along with the burden of evidence for the drug's mechanism of action in the disease and trial design features to predict a probability of progression from one clinical trial stage to the next.

Syntensor Questions

Clayton Rabideau is the Founder, CEO of Syntensor.

8 people are employed at Syntensor.

Syntensor is based in San Francisco, California.

Top Syntensor Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users